310 related articles for article (PubMed ID: 20228420)
21. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain.
Gong JP; Onaivi ES; Ishiguro H; Liu QR; Tagliaferro PA; Brusco A; Uhl GR
Brain Res; 2006 Feb; 1071(1):10-23. PubMed ID: 16472786
[TBL] [Abstract][Full Text] [Related]
22. [Suppression of Schistosoma japonicum eggs on TNBS-induced colitis in mice].
Mo HM; Liu WQ; Lei JH; Cheng YL; Wang CZ; Li YL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Oct; 25(5):381-4. PubMed ID: 18441989
[TBL] [Abstract][Full Text] [Related]
23. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
24. The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment.
Schicho R; Bashashati M; Bawa M; McHugh D; Saur D; Hu HM; Zimmer A; Lutz B; Mackie K; Bradshaw HB; McCafferty DM; Sharkey KA; Storr M
Inflamm Bowel Dis; 2011 Aug; 17(8):1651-64. PubMed ID: 21744421
[TBL] [Abstract][Full Text] [Related]
25. Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation.
Alhouayek M; Lambert DM; Delzenne NM; Cani PD; Muccioli GG
FASEB J; 2011 Aug; 25(8):2711-21. PubMed ID: 21551239
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic changes in TNBS-induced colitis in mice.
Barthet M; Dubucquoy L; Garcia S; Gasmi M; Desreumaux P; Colombel JF; Grimaud JC; Iovanna J; Dagorn JC
Gastroenterol Clin Biol; 2003 Oct; 27(10):895-900. PubMed ID: 14631304
[TBL] [Abstract][Full Text] [Related]
27. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
[TBL] [Abstract][Full Text] [Related]
28. Role of cannabinoid receptors in inhibiting macrophage costimulatory activity.
Chuchawankul S; Shima M; Buckley NE; Hartmann CB; McCoy KL
Int Immunopharmacol; 2004 Feb; 4(2):265-78. PubMed ID: 14996418
[TBL] [Abstract][Full Text] [Related]
29. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice.
Neurath MF; Fuss I; Pasparakis M; Alexopoulou L; Haralambous S; Meyer zum Büschenfelde KH; Strober W; Kollias G
Eur J Immunol; 1997 Jul; 27(7):1743-50. PubMed ID: 9247586
[TBL] [Abstract][Full Text] [Related]
30. Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: the relevance of cannabinoid system.
Matos I; Bento AF; Marcon R; Claudino RF; Calixto JB
Mol Immunol; 2013 Jul; 54(3-4):482-92. PubMed ID: 23454360
[TBL] [Abstract][Full Text] [Related]
31. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
[TBL] [Abstract][Full Text] [Related]
32. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain.
Onaivi ES
Neuropsychobiology; 2006; 54(4):231-46. PubMed ID: 17356307
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
[TBL] [Abstract][Full Text] [Related]
34. Role of TNF-alpha in muscularis inflammation and motility disorder in a TNBS-induced colitis model: clues from TNF-alpha-deficient mice.
Kinoshita K; Hori M; Fujisawa M; Sato K; Ohama T; Momotani E; Ozaki H
Neurogastroenterol Motil; 2006 Jul; 18(7):578-88. PubMed ID: 16771773
[TBL] [Abstract][Full Text] [Related]
35. The effects of charge-neutralizing mutation D6.30N on the functions of CB1 and CB2 cannabinoid receptors.
Nebane NM; Kellie B; Song ZH
FEBS Lett; 2006 Oct; 580(22):5392-8. PubMed ID: 16989818
[TBL] [Abstract][Full Text] [Related]
36. The effect of the cholinergic anti-inflammatory pathway on experimental colitis.
Bai A; Guo Y; Lu N
Scand J Immunol; 2007 Nov; 66(5):538-45. PubMed ID: 17953529
[TBL] [Abstract][Full Text] [Related]
37. Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors.
Braun A; Engel T; Aguilar-Pimentel JA; Zimmer A; Jakob T; Behrendt H; Mempel M
Immunobiology; 2011 Apr; 216(4):466-76. PubMed ID: 21056512
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of β-sitosterol on TNBS-induced colitis in mice.
Lee IA; Kim EJ; Kim DH
Planta Med; 2012 Jun; 78(9):896-8. PubMed ID: 22538477
[TBL] [Abstract][Full Text] [Related]
39. Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors.
Sałaga M; Polepally PR; Zakrzewski PK; Cygankiewicz A; Sobczak M; Kordek R; Zjawiony JK; Krajewska WM; Fichna J
Biochem Pharmacol; 2014 Dec; 92(4):618-26. PubMed ID: 25265540
[TBL] [Abstract][Full Text] [Related]
40. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis.
Liang L; Dong C; Chen X; Fang Z; Xu J; Liu M; Zhang X; Gu DS; Wang D; Du W; Zhu D; Han ZC
Cell Transplant; 2011; 20(9):1395-408. PubMed ID: 21396175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
